In pancreatic adenocarcinoma, ccRCC, and lung adenocarcinoma, PADI1 and PADI3 expression was positively correlated with the hypoxic signature of the different patient samples (Fig. 7a–c). Here, PADI3 is linked to nonpapillary renal cell carcinoma.